NCT03519022View on ClinicalTrials.gov

Behavioral Effects of Drugs: Inpatient (35)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Cocaine Use Disorder
Interventions
DRUG

Cocaine

The pharmacodynamic effects of cocaine will be determined during maintenance on placebo and duloxetine.

DRUG

Placebo oral capsule

The pharmacodynamic effects of placebo will be determined during maintenance on placebo and duloxetine.

DRUG

Methylphenidate

The pharmacodynamic effects of methylphenidate maintenance will be determined during maintenance on placebo and duloxetine.

Trial Locations (1)

40536-0086

University of Kentucky Medical Center, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Craig Rush

OTHER

NCT03519022 - Behavioral Effects of Drugs: Inpatient (35) | Biotech Hunter | Biotech Hunter